Hexagon Bio

Hexagon BioHexagon Bio
Hexagon Bio

Hexagon Bio

Developing novel therapeutics by understanding the complex interplay of biological systems.

2019Active70Menlo Park, United States
Rate

About

Hexagon Bio is a biotechnology company focused on developing new medicines by leveraging a deep understanding of biological pathways and interactions. They aim to create therapies for diseases with high unmet medical needs.

Technology stack

detected 2026-07-14
Email
Stack
SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Hexagon Bio do?

Hexagon Bio is a biotechnology company focused on developing new medicines by leveraging a deep understanding of biological pathways and interactions. They aim to create therapies for diseases with high unmet medical needs.

How much funding has Hexagon Bio raised?

Hexagon Bio has raised a total of $100M in funding. The most recent round on record is Series B.

Where is Hexagon Bio headquartered?

Hexagon Bio is headquartered in Menlo Park, United States.

When was Hexagon Bio founded?

Hexagon Bio was founded in 2019.

What industry does Hexagon Bio operate in?

Hexagon Bio operates in Biotech, Drug Discovery, Genomics, HealthTech, Therapeutics.

How many employees does Hexagon Bio have?

Hexagon Bio has approximately 70 people on record.

What is Hexagon Bio's revenue?

StartupHub estimates Hexagon Bio's annual revenue at $7.7M (range $4.1M to $31.0M, 64% confidence), based on comparable companies in the sector.

What is Hexagon Bio's valuation?

StartupHub estimates Hexagon Bio's effective valuation at $424.0M (range $250.0M to $600.0M, 10% confidence), based on comparable companies in the sector.